Comments
Loading...
Knight Therapeutics (KHTRF) Forecast
NewsEarningsKnight Therapeutics (KHTRF) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestKnight Therapeutics (OTC:KHTRF) Stock Quotes, Forecast and News Summary
Knight Therapeutics Stock (OTC: KHTRF) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Knight Therapeutics (KHTRF) stock?
You can purchase shares of Knight Therapeutics (OTCPK:KHTRF) through any online brokerage.
Who are Knight Therapeutics (KHTRF) competitors?
There are no as such competitors for Knight Therapeutics.
What is the forecast, or price target, for Knight Therapeutics (KHTRF) stock?
Knight Therapeutics has a consensus price target of $7.50.
What is the current price for Knight Therapeutics (KHTRF)?
The stock price for Knight Therapeutics (OTCPK: KHTRF) is $3.769806 last updated November 25, 2024 at 4:05 PM EST.
Does Knight Therapeutics (KHTRF) pay a dividend?
There are no upcoming dividends for Knight Therapeutics.
When is Knight Therapeutics (OTCPK:KHTRF) reporting earnings?
Knight Therapeutics does not have any upcoming earnings scheduled.
Is Knight Therapeutics (KHTRF) going to split?
There is no upcoming split for Knight Therapeutics.
What sector and industry does Knight Therapeutics (KHTRF) operate in?
Knight Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.